The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers

Gynecologic Oncology

Volumn 97, Issue 2, 2005, Pages 342-347

  Chang, Hee Kyung ^a   Park, JongWook ^b   Kim, WooGyeong ^c   Kim, KiTae ^c   Lee, Minyoung ^a   Park, UnDong ^a   Choi, ByungGil ^a  

^a Kosin University   (South Korea)

^b Keimyung University   (South Korea)

^c Inje University   (South Korea)

Author keywords

Common primers; GAGE; HPV 16 and 18; MAGE; Uterine cervical carcinoma

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; PARAFFIN; PRIMER DNA;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DNA SEQUENCE; EVALUATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; KOREA; LYMPH NODE METASTASIS; MELANOMA ANTIGENIC GENE; MOLECULAR CLONING; NEOPLASM; NUCLEOTIDE SEQUENCE; PARAMETER; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX MUCOSA; VIRUS INFECTION;

EID: 18244380810     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.12.051     Document Type: Article

References (32)

1. P. van der Bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, and B. Van den Eynde A gene coding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647
2. P. Chomez, O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas An overview of the MAGE gene family with the identification of all human members of the family Cancer Res. 61 14 2001 5544 5551
3. O. De Backer, K.C. Arden, M. Boretti, V. Vantomme, C. De Smet, and S. Czekay Characterization of the GAGE genes that are expressed in various human cancers and in normal testes Surg. Oncol. 67 2 1998 126 129
4. O. De Backer, K.C. Arden, M. Boretti, V. Vantomme, C. De Smet, and S. Czekay Characterization of the GAGE genes that are expressed in various human cancers and in normal testis Cancer Res. 1 59(13) 1999 3157 3165
5. F.O. Nestle, S. Alijagic, M. Gilliet, Y. Son, S. Grabb, and R. Dummer Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells Nat. Med. 4 1998 328 332
6. M. Marchand, P. Weynants, E. Rankin, F. Arienti, F. Belli, and G. Parmiani Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3 Int. J. Cancer 63 1995 883 885
7. M. Marchand, N. van Baren, P. Weynants, V. Brichard, B. Dreno, and M.H. Tressier Tumor regression observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 Int. J. Cancer 80 1999 219 230
8. B. Thurmer, I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, and H. Jonuleit Vaccination with MAGE-3A 1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced IV melanoma J. Exp. Med. 190 1999 1669 1678
9. S. Osanto Vaccine: trials for the clinician: prospects for tumor antigens Oncologist 2 5 1997 284 299
10. E. De Plaen, K. Arden, C. Traversari, J.J. Gaforio, J.P. Sqikori, and C. DeSmet Structure, chromosomal localization, and expression of 12 genes of the MAGE family Immunogenetics 40 1994 360 369
11. M. Katano, M. Nakamura, T. Morisaki, and K.J. Fujimoto Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease Surg. Oncol. 64 3 1997 195 201
12. M. Zuber, G.C. Spagnoli, T. Kocher, U. Luscher, C. Schaefer, and C. Noppen Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma Eur. Surg. Res. 29 5 1997 403 410
13. A. Yamada, A. Kataoka, S. Shichijo, T. Kamura, Y. Imai, and T. Nishida Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/-4b genes in ovarian tumors Int. J. Cancer 20 64(6) 1995 388 393
14. K.D. Lee, M. Eura, K. Ogi, K. Nakano, K. Chikamatsu, and K. Masuyama Expression of the MAGE-1,-2,-3,-4 and -6 genes in non-squamous cell carcinoma lesions of the head and neck Acta Oto-laryngol. 116 4 1996 633 639
15. K.D. Lee, H.K. Chang, Y.K. Jo, B.S. Kim, B.H. Lee, and Y.W. Lee Expression of MAGE 3 gene product in squamous cell carcinoma of the head and neck Anticancer Res. 19 1999 5037 5042
16. J. Peters, M. Krams, H.H. Wacker, A. Carstens, D. Weisner, and K. Hamann Detection of rare RNA sequences by single-enzyme in situ reverse transcription-polymerase chain reaction Am. J. Pathol. 150 1997 469 476
17. T. Fujie, M. Mori, H. Ueo, K. Sugimachi, and T. Akiyoshi Expression of MAGE and BAGE genes in Japanese breast cancers Ann. Oncol. 8 4 1997 369 372
18. T. Yoshimatsu, I. Yoshino, A. Ohgami, M. Takenoyama, T. Hanagiri, and K. Nomoto Expression of the melanoma antigen-encoding gene in human lung cancer Cancer Res. 1 59(13) 1999 3157 3165
19. K. Tahara, M. Mori, N. Sadanaga, Y. Sakamoto, S. Kitano, and M. Makuuchi Expression of the MAGE gene family in human hepatocellular carcinoma Cancer 15 85(6) 1999 1234 1240
20. S. Shichijo, R. Tsunosue, K. Masuoka, H. Natori, M. Tamai, and J. Miyajima Expression of the MAGE gene family in human lymphocytic leukemia Cancer Immunol. Immunother. 41 1995 95 103
21. H. Hasegawa, M. Mori, M. Haraguchi, H. Ueo, K. Sugimachi, and T. Akiyoshi Expression spectrum of melanoma antigen-encoding gene family members in colorectal carcinoma Arch. Pathol. Lab. Med. 122 6 1998 551 554
22. J.J. Patard, F. Brasseur, S. Gil-Diez, F. Radvanyl, M. Marchand, and P. Francois Expression of MAGE genes in transitional cell carcinoma of the urinary bladder Int. J. Cancer 20 64(1) 1995 60 64
23. E. Stockert, E. Jager, Y.T. Chen, M.J. Scanlan, I. Gout, and J. Karbach Survey of the humoral immune response of cancer patients to a panel of human tumor antigens Exp. Med. 20 187(8) 1998 1349 1354
24. B. Sarvic, G.C. Spagnoli, L. Terracciano, E. Schultz-Thater, M. Heberer, and M. Garmulin Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma Oncology 64 4 2003 443 449
25. A.F. Kirkin, K. Dzhandzhungazyan, and J. Zeuthen Melanoma-associated antigens recognized by cytotoxic T lymphocytes APMIS 106 1998 663 679
26. A. Zambon, S. Mandruzzato, A. Parenti, B. Macino, P. Dalerba, and A. Ruol MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia Cancer 91 2001 1882 1888
27. C. Traversari, P. van der Bruggen, I.F. Luescher, C. Lurquin, P. Chomez, and A. Van Pel A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E J. Exp. Med. 176 1992 1453 1457
28. B. Gaugler, B. Van der Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, and E. De plaen Human MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes J. Exp. Med. 179 1994 921 930
29. P. van der Bruggen, J.P. Szikora, P. Boel, C. Wildmann, M. Somville, and M. Sensi Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanoma expressing HLA-Cw1601 Eur. J. Immunol. 24 1994 2134 2140
30. P. van der Bruggen, J. Bastin, T. Gajewski, P.G. Coulie, P. Boel, and C. De Smet A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3 Eur. J. Immunol. 24 1994 3038 3043
31. B. Van den Eynde, O. Peeters, O. De backer, B. Gaugler, S. Lucas, and T. Boon A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomas J. Exp. Med. 182 1995 689 698
32. S.J. Kim, B. Nisperos, E. Mickelson, I.H. Choi, S. Dahllberg, and J.D. Kim The HLA system in the Korean population Hum. Immunol. 17 1986 259 272